ProteKt Therapeutics
Business Services · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 Ilan Ramon St, Ness Ziona, Central Dis...Phone Number
+972 89553100Website
www.protektx.comRevenue
<$5 MillionIndustry
About ProteKt Therapeutics
ProteKt Therapeutics Org Chart
Is ProteKt Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if ProteKt Therapeutics had a recent Job posting/layoffs
ProteKt Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when ProteKt Therapeutics launches new products
Check if ProteKt Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at ProteKt Therapeutics
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on ProteKt Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once ProteKt Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if ProteKt Therapeutics is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
ProteKt Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ProteKt Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ProteKt Therapeutics.
ProteKt Therapeutics Tech Stack
A closer look at the technologies used by ProteKt Therapeutics
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ProteKt Therapeutics
ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company was founded by Carmel, Haifa University Economic Corporation, and the Carmel Innovations Fund based on the research of Prof. Kobi Rosenblum of... Read More